A therapeutic vibration device includes a body with at least a first vibration element connected to the body, and at least a second vibration element connected to the body. Additionally, at least one audio transducer may be connected to the body. The first vibration element and second vibration element may have vibration characteristics which are different from each other when compared. Additionally, the device may include a controller that is connected to a user input interface which allows the user to control the vibration elements.

A medical device and method of use thereof that provides a new means for administering injectable compounds into a targeted area of skin on the body of a human in an automated or semi-automated way, which eliminates the human factors of subjectivity with regards to placement, depth, volume and coverage.

A method for communicating with devices may include monitoring brain activity of a subject via an EEG monitoring system coupled to the subject. The method also may include detecting a predefined state of brain activity of the subject. Further, based on the detecting the predefined state, the method may include wirelessly transmitting instructions from the EEG monitoring system to the at least one household device to adjust a setting of the at least one household device.

The present disclosure pertains to a system and method for determining sleep onset latency in a subject. The system is configured to generate output signals conveying information related to brain activity in the subject, determine sleep stages of the subject based on the output signals, determine a sleep onset moment in the subject based on the determined sleep stages, determine a sleep intention moment for the subject by: (i) detecting eye blinks in the subject based on the output signals, and determining the sleep intention moment responsive to the detected eye blinks ceasing for a predetermined period of time; and/or (ii) determining whether brain activity power in a target frequency band has breached a threshold power level based on the output signals, and determining the sleep intention moment responsive to a breach; and determine the sleep onset latency based on the sleep onset moment and the sleep intention moment.

The present disclosure pertains to a system configured to facilitate prediction of a sleep stage and intervention preparation in advance of the sleep stage's occurrence. The system comprises sensors configured to be placed on a subject and to generate output signals conveying information related to brain activity of the subject; and processors configured to: determine a sample representing the output signals with respect to a first time period of a sleep session; provide the sample to a prediction model at a first time of the sleep session to predict a sleep stage of the subject occurring around a second time; determine intervention information based on the prediction of the sleep stage, the intervention information indicating one or more stimulator parameters related to periheral stimulation; and cause one or more stimulators to provide the intervention to the subject around the second time of the sleep session.

A PAP system is adapted for treatment of respiratory disease or sleep disordered breathing and includes a headgear adapted for engaging a patient's head. The PAP system also includes a patient interface adapted to be secured to and sealed against a portion of the patient's face, in use, by the headgear. The PAP system further includes a flow generator adapted to be connected to the patient interface. The flow generator is adapted to be secured by a portion of the headgear to the patient's head. In addition, the flow generator includes a blower adapted to provide pressurised breathable gas to a patient through the patient interface. The blower is at least partially vibrationally isolated from the patient's head by at least one foam layer mounted within the flow generator to secure the blower. The at least one foam layer is adapted to reduce the amount of transmitted vibration received by the patient. The flow generator also includes a mounting structure limiting a compression of the at least one foam layer due to the weight of the blower. The mounting structure includes at least one protrusion extending from an interior surface of the flow generator toward the blower.

Described here are positive airway pressure (PAP) systems and methods with various mechanisms for altering the air pressure based in part on the head position of the user. This can be achieved actively or passively. Passively, pressure is altered when head position is altered, as gravity acts to open or close venting elements. Actively, head position information can then be communicated to a controller of the system which may be disposed within the housing having the position sensor or within a separate housing. The controller varies the output pressure of the pressure source, e.g. a rotary compressor, based, at least in part, on the head position information provided.

Methods for treating hydrocephalus using a shunt, the shunt having one or more CSF intake openings in a distal portion, a valve disposed in a proximal portion of the shunt, and a lumen extending between the one or more CSF intake openings and the valve, the method comprises deploying the shunt in a body of a patient so that the distal portion of the shunt is at least partially disposed within a CP angle cistern, a body of the shunt is at least partially disposed within an IPS of the patient, and the proximal portion of the shunt is at least partially disposed within or proximate to a JV of the patient, wherein, after deployment of the shunt, CSF flows from the CP angle cistern to the JV via the shunt lumen at a flow rate in a range of 5 ml per hour to 15 ml per hour.

A head-mounted respiratory assistance apparatus configured to provide a respiratory gases stream to a user. The head-mounted respiratory assistance has a main body securable to the head of a user and a blower unit that is operable to generate a pressurised gases stream from a supply of gases from the surrounding atmosphere. A patient interface is provided on the main body that has a gases inlet which is fluidly connected to the blower unit and which is configured to deliver the pressurised gases to the user's nose and/or mouth.

Methods for treating hydrocephalus using a shunt, the shunt having one or more CSF intake openings in a distal portion, a valve disposed in a proximal portion of the shunt, and a lumen extending between the one or more CSF intake openings and the valve, the method comprises deploying the shunt in a body of a patient so that the distal portion of the shunt is at least partially disposed within a CP angle cistern, a body of the shunt is at least partially disposed within an IPS of the patient, and the proximal portion of the shunt is at least partially disposed within or proximate to a JV of the patient, wherein, after deployment of the shunt, CSF flows from the CP angle cistern to the JV via the shunt lumen at a flow rate in a range of 5 ml per hour to 15 ml per hour.